StonvexLoading…
StonvexStonvexStonvexCore line items from VRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $10.23B | $8.01B | $6.86B | $5.69B |
Operating Income | $1.83B | $1.37B | $872.20M | $223.40M |
Net Income | $1.33B | $495.80M | $460.20M | $76.60M |
EPS (Diluted) | $3.41 | $1.28 | $1.19 | $-0.04 |
Total Assets | $12.21B | $9.13B | $8.00B | $7.10B |
Total Liabilities | $8.27B | $6.70B | $5.98B | $5.65B |
Cash & Equivalents | $1.73B | $1.23B | $780.40M | $260.60M |
Free Cash Flow OCF − CapEx | $1.89B | $1.15B | $772.60M | $-252.80M |
Shares Outstanding | 382.55M | 380.70M | 381.79M | 377.37M |